The kinetics of hematopoietic stem cells during and after hypoxia. A model analysis.
Affiliation
Medizinische Universitätsklinik, Joseph-Stelzmann-Stasse 9, D-5000 Köln 41, Federal Republic of Germany.Issue Date
1984-12
Metadata
Show full item recordAbstract
A previously described mathematical model of the hematopoietic stem cell system has been extended to permit a detailed understanding of the data during and after hypoxia. The model includes stem cells, erythroid and granuloid progenitors and precursors. Concerning the intramedullary feedback mechanisms two basic assumptions are made: 1) The fraction "a" of CFU-S in active cell cycle is regulated. Reduced cell densities of CFU-S, progenitors or precursors lead to an accelerated stem cell cycling. Enlarged cell densities suppress cycling. 2) The self renewal probability "p" of CFU-S is also regulated. The normal steady state is described by p = 0.5, indicating that on statistical average each dividing mother stem cell is replaced by one daughter stem cell, while the second differentiates. Diminished cell densities of CFU-S or enlarged densities of progenitors and precursors induce a more intensive self renewal (p greater than 0.5), such that the stem cell number increases. The self renewal probability declines (p less than 0.5) if too many CFU-S or too few progenitors and precursors are present. The model reproduces bone marrow data for CFU-S, BFU-E, CFU-C, CFU-E, 59 Fe-uptake and nucleated cells in hypoxia and posthypoxia. Although the ratio of differentiation into the erythroid and granuloid cell lines is kept constant in the model, a changing ratio of CFU-E and CFU-C results. The model suggests that stem cells and progenitor cells are regulated by a regulatory interference of erythropoiesis and granulopoiesis.Citation
The kinetics of hematopoietic stem cells during and after hypoxia. A model analysis. 1984, 49 (6):427-39 BlutJournal
BlutDOI
10.1007/BF00320485PubMed ID
6509215Type
ArticleLanguage
enISSN
0006-5242ae974a485f413a2113503eed53cd6c53
10.1007/BF00320485
Scopus Count
Collections
Related articles
- Hemopoiesis during thiamphenicol treatment. II. A theoretical analysis shows consistency of new data with a previously hypothesized model of stem cell regulation.
- Authors: Loeffler M, Bungart B, Goris H, Schmitz S, Nijhof W
- Issue date: 1989 Oct
- Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia.
- Authors: Mide SM, Huygens P, Bozzini CE, Fernandez Pol JA
- Issue date: 2001 Mar-Apr
- Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
- Authors: Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S
- Issue date: 1995 Apr
- Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
- Authors: Miller BA, Lipton JM, Linch DC, Burakoff SJ, Nathan DG
- Issue date: 1985 Apr
- Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice.
- Authors: Goris H, Bungart B, Loeffler M, Schmitz S, Nijhof W
- Issue date: 1990 Jun